Publications by authors named "Ronan Flippot"

Claim this Profile
N
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.
Ronan Flippot, Yann-Alexandre Vano, Cécile Dalban, Benoit Beuselinck, Aude Fléchon

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Circulating IL-6/IL-8 Is Associated with Intratumoral Myeloid Contexture and Poor Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.
Lucía Carril-Ajuria, Ronan Flippot, Marie Naigeon, Cécile Dalban, Aude Desnoyer

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond.
Alice Bernard-Tessier, Natacha Naoun, Solenn Barraud, Ronan Flippot, Cedric Pobel

Ther Adv Med Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAU-RCC spotlight: dual VEGF/EGFR blockade shows promise for reshaping the treatment of papillary RCC in hereditary leiomyomatosis and renal cell cancer syndrome.
Selcuk Erdem, Murat Sari, Laura Marandino, Ronan Flippot, Daniele Amparore

Minerva Urol Nephrol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer.
Jennifer Le Guevelou, Francesco Cuccia, Ronan Flippot, Giuseppe Ferrera, Mario Terlizzi

Prostate Cancer Prostatic Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Intercontinental Multidisciplinary Oncology Videoconferencing between the South Pacific and the French mainland: Reasons for medical evacuation after more than 2000 cases of cancers discussed].
Charles Honoré, Nicolas Epaillard, Arthur Geraud, Ronan Flippot, Gabriel C T E Garcia

Bull Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAU renal cancer spotlight on dual checkpoint inhibition in non-clear cell renal cell carcinoma: a worthy enough contender?
Ronan Flippot, Mariangela Calabrese, Daniele Amparore, Riccardo Campi,

Minerva Urol Nephrol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy.
Roman Vion, Matthieu Roulleaux-Dugage, Ronan Flippot, Kaïssa Ouali, Mathieu Rouanne

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT).
Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, Pritha Roy, Jose C Tapia, Ronan Flippot

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma.
Geraldine Pignot, Gaelle Margue, Pierre Bigot, Hervé Lang, Loïc Balssa, Ronan Flippot

World J Urol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study.
Ronan Flippot, Tugce Telli, Maud Velev, Aude Fléchon, Manon De Vries-Brilland

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma.
Loubna Omri, Marie Naigeon, Ronan Flippot, Javier Gavira-Díaz, Jesus Poveda-Ferriols

Explor Target Antitumor Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.
Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, Guillaume Grisay, Riwan Brillet

NPJ Precis Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.
Ludovic Bigot, Jonathan Sabio, Loic Poiraudeau, Maxime Annereau, Naoual Menssouri, Ronan Flippot

Eur Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Une nouvelle place pour les biomarqueurs circulants dans le cancer du rein en 2024 ?
Ronan Flippot, Lucia Carril-Ajuria

Bull Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, Florent Puisset, David Combarel, Ronan Flippot

Br J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study.
Loïc Mourey, Larissa Tames Rainho, Cécile Dalban, Lucía Carril-Ajuria, Sylvie Negrier, Ronan Flippot

Eur J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors.
Ronan Flippot, Marcus Teixeira, Macarena Rey-Cardenas, Lucia Carril-Ajuria, Larissa Rainho

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
Talal El Zarif, Amin H Nassar, Gregory R Pond, Tony Zibo Zhuang, Viraj Master, Ronan Flippot

J Natl Cancer Inst· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG-AFU 26 NIVOREN.
Guillemette Guilhem-Ducléon, Cécile Dalban, Sylvie Negrier, Gwenaelle Gravis, Brigitte Laguerre, Ronan Flippot

Clin Genitourin Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer.
Clara Helal, Cédric Pobel, Arnaud Bayle, Damien Vasseur, Claudio Nicotra, Ronan Flippot

Eur J Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.
Edwige Baudry, Natacha Naoun, Edouard Auclin, Carolina Saldana, Philippe Barthelemy, Ronan Flippot

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.
Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, Jonathan Dauvé, Christophe Passot, Ronan Flippot

J Immunother Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 T cells in patients with advanced NSCLC.
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, Lisa Boselli, Jean-Mehdi Jouniaux, Ronan Flippot

Sci Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France.
Manuel Rodrigues, Lauriane Eberst, Philippe Follana, Ludiane Gauthier, Virginie Jacquemin, Ronan Flippot

Bull Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis